alfuzosin hydrochloride

It is used to treat the symptoms of moderate to severe benign prostatic hyperplasia, a condition in which the prostate enlarges in a non-cancerous way. It works by relaxing the muscle of the prostate gland to facilitate the flow of urine.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

It is used to treat the symptoms of Benign Prostatic Hyperplasia (BPH), a condition in which the prostate enlarges without being cancerous. Symptoms include the frequent need to urinate (especially at night), difficulty urinating, and the sensation of not having completely emptied the bladder.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: DOC GENERICI SRL

It is used to treat moderate to severe symptoms of an enlarged prostate (benign prostatic hyperplasia), which can cause difficulty or frequency in urination, especially during the night.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: SANDOZ S.P.A.

It is used to treat moderate to severe symptoms caused by an enlarged prostate (benign prostatic hyperplasia) and to facilitate urine flow in cases of acute urinary retention.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: MYLAN S.P.A.

It is used to treat moderate to severe symptoms caused by an enlarged prostate gland (benign prostatic hyperplasia), which can cause difficulty or frequency of urination, especially at night.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: TOWA PHARMACEUTICAL S.P.A.

It is used to treat moderate to severe symptoms of an enlarged prostate (benign prostatic hyperplasia), which can cause difficulty or frequency of urination, especially during the night.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: SANDOZ S.P.A.

It is used to treat disorders caused by an enlarged prostate (benign prostatic hyperplasia) and as an adjunct therapy to catheterization for acute urinary retention caused by an enlarged prostate.

Form: tablets, film-coated

ATC: G04CA01

Manufacturer: ZENTIVA ITALIA S.R.L.

It is used to treat the symptoms of Benign Prostatic Hyperplasia (BPH), a condition in which the prostate increases in size. Symptoms include the frequent need to urinate (especially at night), difficulty urinating, and the sensation of not having completely emptied the bladder.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: FARMA GROUP S.R.L.

The medicine is used to treat disorders caused by benign prostatic hypertrophy (enlarged prostate) and to help treat acute urinary retention caused by prostate enlargement, in combination with the use of a catheter.

Form: tablets

ATC: G04CA01

Manufacturer: SANOFI S.R.L.

The medicine is used to treat the symptoms of benign prostatic hyperplasia (a non-cancerous enlargement of the prostate), such as the frequent need to urinate (especially at night), difficulty urinating, and the sensation of not having completely emptied the bladder. It is also indicated as an adjunct therapy to urethral catheterization for the treatment of acute urinary retention caused by an enlarged prostate.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: LAMPUGNANI FARMACEUTICI SPA

This medicine is used to treat the symptoms of Benign Prostatic Hyperplasia. It helps relax the muscles of the prostate and the urethra, facilitating the passage of urine from the bladder.

Form: tablets, prolonged-release

ATC: G04CA01

Manufacturer: ECUPHARMA S.R.L.

This medicinal product is indicated for the treatment of disorders caused by benign prostatic hyperplasia (enlarged prostate) and to assist in the treatment of acute urinary retention caused by this condition, in addition to catheter use.

Form: tablets, film-coated

ATC: G04CA01

Manufacturer: SANOFI S.R.L.